Cartaz-APTC-Programa
•
0 gostou•327 visualizações
O documento descreve o programa de um workshop e conferência sobre Terapia Cognitivo-Comportamental (TCC) que ocorrerá nos dias 3 e 4. O programa inclui workshops e mesas redondas sobre tópicos como Terapia da Aceitação e Compromisso, Mindfulness, aplicações da TCC em distúrbios mentais e doenças médicas, além de uma assembleia geral no final.
Denunciar
Compartilhar
Denunciar
Compartilhar
Baixar para ler offline
Recomendados
Carta aberta psicopatologia
1) A carta critica a prática de apresentar pacientes psiquiátricos como objetos de estudo na disciplina de psicopatologia, apontando que isso viola a dignidade humana e os direitos dos pacientes.
2) Argumenta que os hospitais psiquiátricos já não devem ser usados para ensino, e que os novos serviços de saúde mental oferecem melhores oportunidades de aprendizagem respeitando os pacientes.
3) Pede aos estudantes que se rebelem contra tais práticas ultrapassadas e pressionem
Jung frankel and the 20th century psychiatry
As we are getting further from the 20th century many historical facts become clearer and clearer. Looking at the past century in perspective helps us to figure out our way forward. Jung and Frankl urged humanity to assimilate the devastation of the two World Wars by taking personal responsibility, and become aware of our projections, such as nationalism. They insist that reason is not enough to prevent future tragedies. These post-World War issues were never dealt with by humanity, just swept under the rug, as in the second half of the 20th century psychiatry identified
with psychopharmacology. Moreover, psychology's self-imposed limitation to the cognitive domain alone, neglecting the study of emotion or introspection is setting the stage for the 21st century repetition of history. The idea is that the current trajectories of both psychiatry and psychology are unsustainable as they direct us towards polarization, thus opening the way for the terrible enantiodromia. The events world-wide such as geographical fragmentation and failure of the nation states are proofs that we, humans have not dealt with our dormant demons.
Frontotemporal dementia and criminal behavior
This document discusses frontotemporal dementia and its relationship with criminal behavior. Some key points:
- Frontotemporal dementia is increasingly common in aging prison populations as inmates live longer. Lesions in brain regions involved in social cognition and morality can cause antisocial acts.
- Patients with frontotemporal dementia are much more likely to exhibit criminal behavior than those with Alzheimer's disease. Criminal behavior may be their first symptom.
- Assessing legal capacity and culpability is challenging in these patients as they may understand rules but be unable to regulate behavior. Screening of older offenders is recommended.
- A modern placement system is needed for neurodegenerative patients that is palliative rather than focused on recovery in
Schizophrenia syndrome
This document provides information on schizophrenia, including its symptoms, course, types, and potential genetic and environmental causes. It notes that schizophrenia is characterized by positive symptoms like delusions and hallucinations as well as negative symptoms and social/occupational dysfunction for at least 6 months. The causes are complex and not fully understood but are thought to involve both genetic and environmental factors. While genes are not thought to directly cause mental illnesses, certain genes may increase risk by encoding for subtle molecular abnormalities.
Aging with meaning
Aging is a natural process defined by time-dependent physiological changes that reduce functional capacity over time. Maximum lifespan for humans is around 120 years, though average life expectancy continues to increase globally due to improvements in public health, medicine, and lifestyle. At the cellular level, aging is influenced by the shortening of telomeres with each cell division as well as a decline in the activity of telomerase. While aging offers no clear evolutionary advantage, humans strive to find meaning even in old age through relationships, creativity, and spiritual fulfillment. Physicians have a duty to report patients with medical conditions like Alzheimer's that could impair driving ability and increase safety risks.
The brain and energy
The document discusses the brain's energy needs and metabolism. It makes three key points:
1. The brain uses 20% of the body's energy despite making up only 2% of body weight. It has no stored energy reserves and relies on a constant supply of oxygen and glucose from the blood.
2. The basic structural and functional unit of the brain is the neurovascular unit (NVU), which generates energy locally through metabolism to power synaptic transmission and information processing.
3. Functional magnetic resonance imaging (fMRI) detects increased blood flow and oxygen delivery to active brain regions during cognitive tasks, revealing how neural activity triggers rapid local hyperemia through volume transmission of vasoactive signals within the NVU
Preventing delirium in geroforensic population
This document discusses delirium in geriatric psychiatric patients. It begins with two case studies of elderly patients presenting with delirium and provides the DSM-5 and ICD-10 diagnostic criteria for delirium. It then discusses how delirium is underrecognized, especially in psychiatric settings where its symptoms can overlap with primary psychiatric disorders. Risk factors for delirium in this population include cognitive impairment, medical illnesses, and medications. The document emphasizes that delirium is a medical emergency that requires prompt treatment to prevent permanent brain damage and higher mortality. Prevention through careful management of risk factors is important.
Genomic and proyeomic markers in forensic psychiatry
This document provides an overview of genomic and proteomic markers in forensic psychiatry. It discusses various topics including:
- Genomic markers for fragile X syndrome and their role in the courtroom
- The neurobiology of morality and disorders that impact moral behavior
- Proteomic markers like misfolded proteins that can cause neurodegenerative diseases
- How disorders like frontotemporal dementia can result in acquired sociopathy due to neurodegeneration impacting moral processing centers in the brain
- The importance of understanding these biological factors for clinicians working in forensic psychiatry
Recomendados
Carta aberta psicopatologia
1) A carta critica a prática de apresentar pacientes psiquiátricos como objetos de estudo na disciplina de psicopatologia, apontando que isso viola a dignidade humana e os direitos dos pacientes.
2) Argumenta que os hospitais psiquiátricos já não devem ser usados para ensino, e que os novos serviços de saúde mental oferecem melhores oportunidades de aprendizagem respeitando os pacientes.
3) Pede aos estudantes que se rebelem contra tais práticas ultrapassadas e pressionem
Jung frankel and the 20th century psychiatry
As we are getting further from the 20th century many historical facts become clearer and clearer. Looking at the past century in perspective helps us to figure out our way forward. Jung and Frankl urged humanity to assimilate the devastation of the two World Wars by taking personal responsibility, and become aware of our projections, such as nationalism. They insist that reason is not enough to prevent future tragedies. These post-World War issues were never dealt with by humanity, just swept under the rug, as in the second half of the 20th century psychiatry identified
with psychopharmacology. Moreover, psychology's self-imposed limitation to the cognitive domain alone, neglecting the study of emotion or introspection is setting the stage for the 21st century repetition of history. The idea is that the current trajectories of both psychiatry and psychology are unsustainable as they direct us towards polarization, thus opening the way for the terrible enantiodromia. The events world-wide such as geographical fragmentation and failure of the nation states are proofs that we, humans have not dealt with our dormant demons.
Frontotemporal dementia and criminal behavior
This document discusses frontotemporal dementia and its relationship with criminal behavior. Some key points:
- Frontotemporal dementia is increasingly common in aging prison populations as inmates live longer. Lesions in brain regions involved in social cognition and morality can cause antisocial acts.
- Patients with frontotemporal dementia are much more likely to exhibit criminal behavior than those with Alzheimer's disease. Criminal behavior may be their first symptom.
- Assessing legal capacity and culpability is challenging in these patients as they may understand rules but be unable to regulate behavior. Screening of older offenders is recommended.
- A modern placement system is needed for neurodegenerative patients that is palliative rather than focused on recovery in
Schizophrenia syndrome
This document provides information on schizophrenia, including its symptoms, course, types, and potential genetic and environmental causes. It notes that schizophrenia is characterized by positive symptoms like delusions and hallucinations as well as negative symptoms and social/occupational dysfunction for at least 6 months. The causes are complex and not fully understood but are thought to involve both genetic and environmental factors. While genes are not thought to directly cause mental illnesses, certain genes may increase risk by encoding for subtle molecular abnormalities.
Aging with meaning
Aging is a natural process defined by time-dependent physiological changes that reduce functional capacity over time. Maximum lifespan for humans is around 120 years, though average life expectancy continues to increase globally due to improvements in public health, medicine, and lifestyle. At the cellular level, aging is influenced by the shortening of telomeres with each cell division as well as a decline in the activity of telomerase. While aging offers no clear evolutionary advantage, humans strive to find meaning even in old age through relationships, creativity, and spiritual fulfillment. Physicians have a duty to report patients with medical conditions like Alzheimer's that could impair driving ability and increase safety risks.
The brain and energy
The document discusses the brain's energy needs and metabolism. It makes three key points:
1. The brain uses 20% of the body's energy despite making up only 2% of body weight. It has no stored energy reserves and relies on a constant supply of oxygen and glucose from the blood.
2. The basic structural and functional unit of the brain is the neurovascular unit (NVU), which generates energy locally through metabolism to power synaptic transmission and information processing.
3. Functional magnetic resonance imaging (fMRI) detects increased blood flow and oxygen delivery to active brain regions during cognitive tasks, revealing how neural activity triggers rapid local hyperemia through volume transmission of vasoactive signals within the NVU
Preventing delirium in geroforensic population
This document discusses delirium in geriatric psychiatric patients. It begins with two case studies of elderly patients presenting with delirium and provides the DSM-5 and ICD-10 diagnostic criteria for delirium. It then discusses how delirium is underrecognized, especially in psychiatric settings where its symptoms can overlap with primary psychiatric disorders. Risk factors for delirium in this population include cognitive impairment, medical illnesses, and medications. The document emphasizes that delirium is a medical emergency that requires prompt treatment to prevent permanent brain damage and higher mortality. Prevention through careful management of risk factors is important.
Genomic and proyeomic markers in forensic psychiatry
This document provides an overview of genomic and proteomic markers in forensic psychiatry. It discusses various topics including:
- Genomic markers for fragile X syndrome and their role in the courtroom
- The neurobiology of morality and disorders that impact moral behavior
- Proteomic markers like misfolded proteins that can cause neurodegenerative diseases
- How disorders like frontotemporal dementia can result in acquired sociopathy due to neurodegeneration impacting moral processing centers in the brain
- The importance of understanding these biological factors for clinicians working in forensic psychiatry
Normal aging
This document discusses several topics related to normal aging:
1. It defines aging and discusses concepts like life expectancy, maximum lifespan, cellular and organismal aging. It mentions things like rapamycin, progeria, and telomeres.
2. It discusses aging and cancer, and mentions elderly drivers.
3. It briefly describes stories from Greek mythology about Eos and Tithonus that are relevant to aging.
4. It provides several short summaries and quotes on topics like whether aging provides an evolutionary advantage, whether old age is a uniquely human achievement, facing memory loss and the unknown in old age, and perspectives on aging with meaning.
Factitious disorders
This document provides an overview of factitious disorder, including its history, definitions, subtypes, proposed causes and risk factors, demographics of those affected, treatment approaches, and diagnostic testing considerations. It describes how factitious disorder was first documented by Galen and later studied by Richard Asher in 1951. Key points covered include the deliberate falsification of physical or psychological symptoms for the purpose of assuming the sick role, potential psychodynamic drivers like seeking attention or nurturing, and challenges in treating those diagnosed due to lack of follow through.
Psychosis and antipsychotics (1)
This document discusses psychosis, antipsychotics, and the brain. It begins with definitions of psychosis and descriptions of biological markers and FDA-approved antipsychotics of the past decade. It then discusses computational models of psychosis and the relationship between psychosis, antipsychotics, and brain tissue loss. The document also discusses patient-specific cultured neurons and summarizes key points about conventional versus atypical antipsychotics. The rest of the document details various antipsychotics approved in the past decade, events shaping antipsychotic development, advances in neuroimaging and connectomics in schizophrenia research. It discusses causes and substances related to psychosis and default mode networks in the brain. The document concludes by discussing brain changes associated with antip
Schizophrenia Past, Present and Future
Schizophrenia is a collection of neurodevelopmental disorders involving alterations in brain circuits during early development. While psychosis occurs late, prevention is key. Recent research integrates genetics, neuroimaging, biomarkers and patient-specific cell cultures to map pathophysiology across stages. This enables early detection, personalized treatment selection and outcome monitoring. Going forward, multidimensional classification systems may integrate these data to transform care through prevention, early intervention and integrated treatment approaches.
Tryptophan and madness
Tryptophan metabolism and the kynurenine pathway play an important role in neuropsychiatric disorders and immune regulation. Tryptophan is converted to kynurenine via the enzymes IDO and TDO, with kynurenine then processed differently by astrocytes and microglia in the brain. Pro-inflammatory cytokines increase IDO/TDO activity, depleting tryptophan and producing neurotoxic metabolites, while anti-inflammatory cytokines decrease their activity. Abnormalities in this pathway have been linked to depression, psychosis, Alzheimer's, and autoimmune diseases. IDO also plays a key role in immune tolerance by inhibiting T-cell responses and preventing rejection of the fetus during
Drugs and the brain
1. The document discusses how psychotropic medications work in the brain and their potential side effects. It describes how drugs travel through different compartments in the brain, including the blood vessels, extracellular space, and between brain cells, before reaching their targets.
2. Many psychotropic drugs target neurotransmitter transporter proteins, G protein-linked receptors, ligand-gated ion channels, voltage-sensitive ion channels, or enzymes in the brain. Their effects are not selective to specific brain regions, which can contribute to side effects.
3. Common side effects discussed include tardive dyskinesia from long-term use of antipsychotics and weight gain from some atypical antipsychotics, which
Programa do II Semanário RPM
Este documento apresenta o programa detalhado para o II Seminário de Reabilitação Psicomotora, que inclui sessões de abertura, mesas sobre desenvolvimento psicomotor, dificuldades de aprendizagem e intervenção psicomotora, além de workshops sobre diversos temas relacionados à psicomotricidade. O evento ocorre nos dias 12 e 13 de março na Universidade de Trás-os-Montes e Alto Douro e aborda questões como avaliação, diagnóstico e intervenção em psicomotricidade.
PROGRAMA "Forum Internacional Noite Saudável das Cidades"
Este documento descreve o programa de um fórum internacional sobre noites saudáveis nas cidades que ocorrerá em Coimbra, Portugal entre 4-6 de maio de 2016. O fórum irá discutir políticas e práticas preventivas relacionadas a contextos recreativos noturnos e seus riscos para a saúde. O programa inclui sessões plenárias, debates, seminários e palestrantes de Portugal, França, Bélgica, Reino Unido, Espanha, Angola e Equador.
I Simpósio sobre a Adolescência - Problemáticas e Perspetivas da Geração Mill...
Este documento descreve o programa de um seminário sobre os desafios da adolescência e a geração millenium. O seminário inclui dois painéis com especialistas discutindo tópicos como a prevenção, comportamentos de risco, alimentação e autolesão em adolescentes, e as perspectivas de futuro para os jovens. Também apresenta os Dream Teens, um projeto que cria uma rede de jovens consultores.
Programa final
Este documento descreve o programa de um seminário de dois dias sobre reabilitação psicomotora. O seminário inclui sessões sobre o enquadramento, desenvolvimento e dificuldades de aprendizagem em psicomotricidade, além de workshops e mesas redondas sobre diferentes contextos de intervenção psicomotora. O segundo dia foca na avaliação e intervenção em psicomotricidade e inclui testemunhos sobre a integração profissional de licenciados.
Programa final
Este documento descreve o programa de um seminário de dois dias sobre reabilitação psicomotora. O seminário inclui sessões sobre o enquadramento, desenvolvimento e dificuldades de aprendizagem em psicomotricidade, além de workshops e mesas redondas sobre diferentes contextos de intervenção psicomotora. O segundo dia foca na avaliação e intervenção em psicomotricidade e inclui testemunhos sobre a integração profissional de licenciados.
Programa do II Seminário de RPM
Este documento descreve o programa de um seminário de dois dias sobre reabilitação psicomotora. O seminário inclui sessões sobre o enquadramento, desenvolvimento e dificuldades de aprendizagem em psicomotricidade, além de workshops e mesas redondas sobre diferentes contextos de intervenção psicomotora. O segundo dia foca na avaliação e intervenção em psicomotricidade e inclui testemunhos sobre a integração profissional de licenciados.
Mais conteúdo relacionado
Destaque
Normal aging
This document discusses several topics related to normal aging:
1. It defines aging and discusses concepts like life expectancy, maximum lifespan, cellular and organismal aging. It mentions things like rapamycin, progeria, and telomeres.
2. It discusses aging and cancer, and mentions elderly drivers.
3. It briefly describes stories from Greek mythology about Eos and Tithonus that are relevant to aging.
4. It provides several short summaries and quotes on topics like whether aging provides an evolutionary advantage, whether old age is a uniquely human achievement, facing memory loss and the unknown in old age, and perspectives on aging with meaning.
Factitious disorders
This document provides an overview of factitious disorder, including its history, definitions, subtypes, proposed causes and risk factors, demographics of those affected, treatment approaches, and diagnostic testing considerations. It describes how factitious disorder was first documented by Galen and later studied by Richard Asher in 1951. Key points covered include the deliberate falsification of physical or psychological symptoms for the purpose of assuming the sick role, potential psychodynamic drivers like seeking attention or nurturing, and challenges in treating those diagnosed due to lack of follow through.
Psychosis and antipsychotics (1)
This document discusses psychosis, antipsychotics, and the brain. It begins with definitions of psychosis and descriptions of biological markers and FDA-approved antipsychotics of the past decade. It then discusses computational models of psychosis and the relationship between psychosis, antipsychotics, and brain tissue loss. The document also discusses patient-specific cultured neurons and summarizes key points about conventional versus atypical antipsychotics. The rest of the document details various antipsychotics approved in the past decade, events shaping antipsychotic development, advances in neuroimaging and connectomics in schizophrenia research. It discusses causes and substances related to psychosis and default mode networks in the brain. The document concludes by discussing brain changes associated with antip
Schizophrenia Past, Present and Future
Schizophrenia is a collection of neurodevelopmental disorders involving alterations in brain circuits during early development. While psychosis occurs late, prevention is key. Recent research integrates genetics, neuroimaging, biomarkers and patient-specific cell cultures to map pathophysiology across stages. This enables early detection, personalized treatment selection and outcome monitoring. Going forward, multidimensional classification systems may integrate these data to transform care through prevention, early intervention and integrated treatment approaches.
Tryptophan and madness
Tryptophan metabolism and the kynurenine pathway play an important role in neuropsychiatric disorders and immune regulation. Tryptophan is converted to kynurenine via the enzymes IDO and TDO, with kynurenine then processed differently by astrocytes and microglia in the brain. Pro-inflammatory cytokines increase IDO/TDO activity, depleting tryptophan and producing neurotoxic metabolites, while anti-inflammatory cytokines decrease their activity. Abnormalities in this pathway have been linked to depression, psychosis, Alzheimer's, and autoimmune diseases. IDO also plays a key role in immune tolerance by inhibiting T-cell responses and preventing rejection of the fetus during
Drugs and the brain
1. The document discusses how psychotropic medications work in the brain and their potential side effects. It describes how drugs travel through different compartments in the brain, including the blood vessels, extracellular space, and between brain cells, before reaching their targets.
2. Many psychotropic drugs target neurotransmitter transporter proteins, G protein-linked receptors, ligand-gated ion channels, voltage-sensitive ion channels, or enzymes in the brain. Their effects are not selective to specific brain regions, which can contribute to side effects.
3. Common side effects discussed include tardive dyskinesia from long-term use of antipsychotics and weight gain from some atypical antipsychotics, which
Destaque (6)
Semelhante a Cartaz-APTC-Programa
Programa do II Semanário RPM
Este documento apresenta o programa detalhado para o II Seminário de Reabilitação Psicomotora, que inclui sessões de abertura, mesas sobre desenvolvimento psicomotor, dificuldades de aprendizagem e intervenção psicomotora, além de workshops sobre diversos temas relacionados à psicomotricidade. O evento ocorre nos dias 12 e 13 de março na Universidade de Trás-os-Montes e Alto Douro e aborda questões como avaliação, diagnóstico e intervenção em psicomotricidade.
PROGRAMA "Forum Internacional Noite Saudável das Cidades"
Este documento descreve o programa de um fórum internacional sobre noites saudáveis nas cidades que ocorrerá em Coimbra, Portugal entre 4-6 de maio de 2016. O fórum irá discutir políticas e práticas preventivas relacionadas a contextos recreativos noturnos e seus riscos para a saúde. O programa inclui sessões plenárias, debates, seminários e palestrantes de Portugal, França, Bélgica, Reino Unido, Espanha, Angola e Equador.
I Simpósio sobre a Adolescência - Problemáticas e Perspetivas da Geração Mill...
Este documento descreve o programa de um seminário sobre os desafios da adolescência e a geração millenium. O seminário inclui dois painéis com especialistas discutindo tópicos como a prevenção, comportamentos de risco, alimentação e autolesão em adolescentes, e as perspectivas de futuro para os jovens. Também apresenta os Dream Teens, um projeto que cria uma rede de jovens consultores.
Programa final
Este documento descreve o programa de um seminário de dois dias sobre reabilitação psicomotora. O seminário inclui sessões sobre o enquadramento, desenvolvimento e dificuldades de aprendizagem em psicomotricidade, além de workshops e mesas redondas sobre diferentes contextos de intervenção psicomotora. O segundo dia foca na avaliação e intervenção em psicomotricidade e inclui testemunhos sobre a integração profissional de licenciados.
Programa final
Este documento descreve o programa de um seminário de dois dias sobre reabilitação psicomotora. O seminário inclui sessões sobre o enquadramento, desenvolvimento e dificuldades de aprendizagem em psicomotricidade, além de workshops e mesas redondas sobre diferentes contextos de intervenção psicomotora. O segundo dia foca na avaliação e intervenção em psicomotricidade e inclui testemunhos sobre a integração profissional de licenciados.
Programa do II Seminário de RPM
Este documento descreve o programa de um seminário de dois dias sobre reabilitação psicomotora. O seminário inclui sessões sobre o enquadramento, desenvolvimento e dificuldades de aprendizagem em psicomotricidade, além de workshops e mesas redondas sobre diferentes contextos de intervenção psicomotora. O segundo dia foca na avaliação e intervenção em psicomotricidade e inclui testemunhos sobre a integração profissional de licenciados.
Semelhante a Cartaz-APTC-Programa (6)
PROGRAMA "Forum Internacional Noite Saudável das Cidades"
PROGRAMA "Forum Internacional Noite Saudável das Cidades"
I Simpósio sobre a Adolescência - Problemáticas e Perspetivas da Geração Mill...
I Simpósio sobre a Adolescência - Problemáticas e Perspetivas da Geração Mill...
Cartaz-APTC-Programa
- 1. dia 3 | 14.00 - 19.00 Workshop – Terapia da Aceitação e Compromisso – ACT como una terapia contextual desde la raíz - Cármen Luciano Soriano. Almería, Espanha dia 4 | 08.30 – 19.00 Conferencias Ingredientes na formação dos psicoterapeutas cognitivo-comportamentais de 3ª geração - Serafim Carvalho. Presidente da APTC. Porto Integração das três gerações da terapia cognitivo-comportamental (TCC) - José Pinto Gouveia. Coimbra ACT & TCC- La condición humana, los problemas psicológicos y la ciencia contextual - Cármen Luciano Soriano. Almería, Espanha Mesa redonda | Mindfulness: aplicações ao longo da vida Mindfulness na TCC com crianças e adolescentes - Carlos Carona. Coimbra Mindfulness na idade adulta: encontrar paz num mundo frenético - Joana Duarte. Coimbra Mindfulness e TCC na idade avançada - Margarida Pedroso de Lima. Coimbra Mesa redonda | TCC & Doença Mental TCC nas psicoses esquizofrénicas - Luiz Gamito. Lisboa Terapia comportamental dialética na perturbação borderline - Paula Castilho. Coimbra TCC na Fobia a voo - Cristina Albuquerque. Lisboa Mesa redonda | TCC & Doença Médica Importância de integrar as terapias de 3ª geração na TCC da diabetes - Paula Matos. Coimbra Intervenções TCC na oncologia - Cristina Nave. Lisboa Da TCC às abordagens contextuais no tratamento da obesidade - Lara Palmeira. Coimbra Assembleia Geral e eleição dos Corpos Sociais da APTC organização comissão científica Afonso de Albuquerque Américo Baptista José Pacheco José Pinto Gouveia Luiz Gamito Óscar Gonçalves Serafim Carvalho comissão executiva Ana Galhardo Ana Godinho Ana Sofia Pinto Cátia Priscila Lígia Fonseca Marco Pereira Maria do Céu Salvador Marina Cunha Paulo Pimentel Susana Veloso apoios secretariado Luís Jorge Pais ljdsecretariado@gmail.com